Sabra Health Care REIT (SBRA) Stock Price, News & Analysis

Company Overview

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures. As of September 30, 2023, Sabra's real estate properties held for investment included 37,606 beds/units, spread across the United States and Canada.

Key Stats

• Today's Range: $16.53 to $17.09
• 50-Day Range: $16.73 to $19.67
• 52-Week Range: $12.83 to $20.03
• Volume: 5.43 million shs
• Average Volume: 2.06 million shs
• Market Capitalization: $4.01 billion
• P/E Ratio: 41.37
• Dividend Yield: 7.08%
• Price Target: $19.14
• Consensus Rating: Moderate Buy

Sabra Health Care REIT Stock Analysis - MarketRank™

Sabra Health Care REIT scored higher than 36% of companies evaluated by MarketBeat, and ranked 751st out of 935 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Sabra Health Care REIT has received a consensus rating of Moderate Buy. The company's average rating score is 2.71, and is based on 5 buy ratings, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Sabra Health Care REIT has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 4.32%

Earnings Growth

Earnings for Sabra Health Care REIT are expected to grow by 4.32% in the coming year, from $1.39 to $1.45 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Sabra Health Care REIT is 41.37, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 113.29.

Price to Earnings Ratio vs. Sector

The P/E ratio of Sabra Health Care REIT is 41.37, which means that it is trading at a more expensive P/E ratio than the Finance sector average P/E ratio of about 26.71.

Price to Earnings Growth Ratio

Sabra Health Care REIT has a PEG Ratio of 2.20. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Sabra Health Care REIT has a P/B Ratio of 1.40. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

7.82% of the outstanding shares of Sabra Health Care REIT have been sold short.

Short Interest Ratio / Days to Cover

Sabra Health Care REIT has a short interest ratio ("days to cover") of 9.

Change versus previous month

Short interest in Sabra Health Care REIT has recently increased by 3.01%, indicating that investor sentiment is decreasing.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

Sabra Health Care REIT is a leading dividend payer. It pays a dividend yield of 7.10%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Sabra Health Care REIT does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Sabra Health Care REIT is 292.68%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on EPS estimates, Sabra Health Care REIT will have a dividend payout ratio of 82.76% in the coming year. This indicates that Sabra Health Care REIT may not be able to sustain their current dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

7.82% of the outstanding shares of Sabra Health Care REIT have been sold short.

Short Interest Ratio / Days to Cover

Sabra Health Care REIT has a short interest ratio ("days to cover") of 9.

Change versus previous month

Short interest in Sabra Health Care REIT has recently increased by 3.01%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 2.3 / 5
• News Sentiment: 1.10

News Sentiment

Sabra Health Care REIT has a news sentiment score of 1.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.77 average news sentiment score of Finance companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Sabra Health Care REIT this week, compared to 4 articles on an average week.

Search Interest

Only 4 people have searched for SBRA on MarketBeat in the last 30 days. This is a decrease of -69% compared to the previous 30 days.

MarketBeat Follows

Only 5 people have added Sabra Health Care REIT to their MarketBeat watchlist in the last 30 days. This is a decrease of -29% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Sabra Health Care REIT insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 1.10% of the stock of Sabra Health Care REIT is held by insiders.

Percentage Held by Institutions

99.40% of the stock of Sabra Health Care REIT is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

SBRA Stock Analysis - Frequently Asked Questions

How have SBRA shares performed this year?

Sabra Health Care REIT's stock was trading at $14.27 at the beginning of the year. Since then, SBRA shares have increased by 18.9% and is now trading at $16.96.
View the best growth stocks for 2024 here.

How were Sabra Health Care REIT's earnings last quarter?

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) posted its quarterly earnings results on Thursday, October, 31st. The real estate investment trust reported $0.13 EPS for the quarter, missing the consensus estimate of $0.35 by $0.22. The real estate investment trust had revenue of $178 million for the quarter, compared to analyst estimates of $177.19 million. Sabra Health Care REIT had a net margin of 14.20% and a trailing twelve-month return on equity of 3.51%.

Who are Sabra Health Care REIT's major shareholders?

Top institutional investors of Sabra Health Care REIT include Principal Financial Group Inc. (9.12%), State Street Corp (4.94%), Geode Capital Management LLC (2.66%) and Charles Schwab Investment Management Inc. (1.99%). Insiders that own company stock include Michael Lourenco Costa, Catherine Cusack and Harold W Jr Andrews.
View institutional ownership trends.

How do I buy shares of Sabra Health Care REIT?

Shares of SBRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Sabra Health Care REIT own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Sabra Health Care REIT investors own include NVIDIA (NVDA), AT&T (T), Meta Platforms (META), Verizon Communications (VZ), Chevron (CVX), Tesla (TSLA) and Exxon Mobil (XOM).

Company Calendar

• Last Earnings: 10/31/2024
• Ex-Dividend for 11/29 Dividend: 11/15/2024
• Dividend Payable: 11/29/2024
• Today: 12/21/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: Real estate investment trusts
• Sub-Industry: Specialized REITs
• Current Symbol: NASDAQ:SBRA
• CUSIP: 78573L10
• CIK: 1492298
• Web: www.sabrahealth.com
• Phone: (888) 393-8248
• Fax: 949-679-8868
• Employees: 40
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $19.14
• High Stock Price Target: $21.00
• Low Stock Price Target: $17.00
• Potential Upside/Downside: +12.9%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.71
• Research Coverage: 7 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $0.41
• Trailing P/E Ratio: 41.37
• Forward P/E Ratio: 12.20
• P/E Growth: 2.2
• Net Income: $13.76 million
• Net Margins: 14.20%
• Pretax Margin: 14.52%
• Return on Equity: 3.51%
• Return on Assets: 1.81%

Debt

• Debt-to-Equity Ratio: 0.90
• Current Ratio: 4.16
• Quick Ratio: 4.16

Sales & Book Value

• Annual Sales: $684.29 million
• Price / Sales: 5.86
• Cash Flow: $0.82 per share
• Price / Cash Flow: 20.56
• Book Value: $12.12 per share
• Price / Book: 1.40

Miscellaneous

• Outstanding Shares: 236,587,000
• Free Float: 233,985,000
• Market Cap: $4.01 billion
• Optionable: Optionable
• Beta: 1.24